Stay updated on Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.

Latest updates to the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision label shows v3.5.4, replacing the previous v3.5.3. This indicates a minor internal update to the page without changes to the main content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page’s technical revision/version footer was updated from v3.5.2 to v3.5.3, indicating a tooling or publishing update rather than a change to the study record content.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. The visible study details appear unchanged in the current view.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check91 days agoChange DetectedUpdated the Study Record Dates with a new last update posted on 2026-02-24 and a new last update submitted on 2026-02-20. Older dates (e.g., 2025-01-08, 2025-01-06) were removed.SummaryDifference0.3%

Stay in the know with updates to Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.